Slideshow

Diabetes News Roundup: October 2018

Author(s):

Mark L. Fuerst

Highlights include: "Artificial pancreas" improves glucose control; T1DM often misdiagnosed as T2DM; and a genetic connection for “type 1.5 diabetes.” 

Related Videos
Evaluating the Medtronic 780G System in Type 2 Diabetes | Image Credit: HCPLive
Understanding Omnipod 5 AID and SECURE-T2D | Image Credit: HCPLive
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Related Content
FDA News Month in Review: January 2025 | Image Credit: HCPLive
February 28th 2025

FDA News Month in Review: February 2025

Victoria Johnson
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
February 15th 2025

Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy) | Image Credit: US Food and Drug Administration
February 21st 2025

FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy)

Connor Iapoce
Medical Ethics Unpacked: GLP-1 Allocation
February 5th 2025

Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access

Steve Levine, MD Dominic Sisti, PhD
FDA
February 14th 2025

FDA Approves Merilog, Biosimilar Product of Insulin Aspart (Novolog) for Diabetes

Chelsie Derman
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes | Image Credit: LinkedIn
February 11th 2025

CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.